These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21305033)

  • 1. The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice.
    Yamada M; Ihara M; Okamoto Y; Maki T; Washida K; Kitamura A; Hase Y; Ito H; Takao K; Miyakawa T; Kalaria RN; Tomimoto H; Takahashi R
    PLoS One; 2011 Jan; 6(1):e16567. PubMed ID: 21305033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice.
    Kitaguchi H; Tomimoto H; Ihara M; Shibata M; Uemura K; Kalaria RN; Kihara T; Asada-Utsugi M; Kinoshita A; Takahashi R
    Brain Res; 2009 Oct; 1294():202-10. PubMed ID: 19646974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice.
    Salvadores N; Searcy JL; Holland PR; Horsburgh K
    Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease.
    King DL; Arendash GW; Crawford F; Sterk T; Menendez J; Mullan MJ
    Behav Brain Res; 1999 Sep; 103(2):145-62. PubMed ID: 10513583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo.
    Khan AA; Mao XO; Banwait S; Jin K; Greenberg DA
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19114-9. PubMed ID: 18025470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats.
    Li WX; Deng YY; Li F; Liu B; Liu HY; Shi JS; Gong QH
    Pharmacol Biochem Behav; 2015 Nov; 138():40-8. PubMed ID: 26364923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
    Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.
    Zhiyou C; Yong Y; Shanquan S; Jun Z; Liangguo H; Ling Y; Jieying L
    Neurochem Res; 2009 Jul; 34(7):1226-35. PubMed ID: 19123057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease.
    Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R
    Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alcohol intake on cognitive function and β-amyloid protein in APP/PS1 transgenic mice.
    Gong YS; Hou FL; Guo J; Lin L; Zhu FY
    Food Chem Toxicol; 2021 May; 151():112105. PubMed ID: 33737111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion.
    Xi Y; Wang M; Zhang W; Bai M; Du Y; Zhang Z; Li Z; Miao J
    Neurobiol Learn Mem; 2014 Mar; 109():7-19. PubMed ID: 24315928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.
    Araki W; Oda A; Motoki K; Hattori K; Itoh M; Yuasa S; Konishi Y; Shin RW; Tamaoka A; Ogino K
    Curr Alzheimer Res; 2013 Feb; 10(2):135-42. PubMed ID: 22742855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.
    Chung E; Ji Y; Sun Y; Kascsak RJ; Kascsak RB; Mehta PD; Strittmatter SM; Wisniewski T
    BMC Neurosci; 2010 Oct; 11():130. PubMed ID: 20946660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of memory impairment and cholinergic disturbance in a mouse model of Alzheimer's disease by mild ischemic burden.
    Watanabe T; Takasaki K; Yamagata N; Fujiwara M; Iwasaki K
    Neurosci Lett; 2013 Mar; 536():74-9. PubMed ID: 23295908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.